This report is part of GlobalData's Success and Failures case study series, which explores the reasons underpinning success or failure, and key learnings. This particular case is regarding a bar that is focused on minimizing its carbon footprint, which had gained a considerable amount of consumer interest.

Penicillin is the first zero-waste bar in Hong Kong, launched in November 2020. The brand was inspired by the origin of penicillin itself, which was discovered in the 1940s by Alexander Fleming. The product was a breakthrough in modern medicine, which had inspired the company to replicate this concept in the context of sustainability, and the décor of the bar has similarities to a laboratory.

The key regions in the Glioblastoma multiforme (GBM) clinical trial market are North America, Europe, Asia-Pacific, Middle East and Africa, and South and Central America. North America has the highest number of clinical trials.

Glioblastoma multiforme (GBM) clinical trial market in Asia-Pacific

China, Australia, Japan, South Korea, and India are the key countries in the glioblastoma multiforme (GBM) clinical trial market. Amongst them China has the highest number of clinical trials.

Glioblastoma multiforme (GBM) clinical trial market in Europe

France, Germany, Italy, Spain, the United Kingdom are the key countries of Europe in the glioblastoma multiforme (GBM) clinical trial market. Amongst them Germany has the highest number of clinical trials.

Glioblastoma multiforme (GBM) clinical trial market in North America

The US, Canada, and Mexico are the key countries in North America in the glioblastoma multiforme (GBM) clinical trial market. The US has the highest number of clinical trials amongst them.

GlobalData’s clinical trial report, “Non-Alcoholic Steatohepatitis (NASH) – Global Clinical Trials Review, 2022″ provides an overview of Non-Alcoholic Steatohepatitis (NASH) Clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Alcoholic Steatohepatitis (NASH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma – Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

These are endoscopes which are used for treatment of conditions of the central nervous system. GlobalData's Medical Devices sector report, “Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Neurosurgical Products pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Neurosurgical Products report provides key information and data related to: Extensive coverage of the Neurosurgical Products under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates Reviews of major players involved in the pipeline product development. Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Neurosurgical Products pipeline products. Review of Recent Developments in the segment / industry The Neurosurgical Products report enables you to: Access significant competitor information, analysis, and insights to improve your R&D strategies Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage Identify and understand important and diverse types of Neurosurgical Products under development Formulate market-entry and market expansion strategies Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. The GlobalData Differentiation This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following: • 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025 • 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports • 64,000+ medical equipment company profiles • 5,600+ company profiles of medical equipment manufacturers in China and India • 2,200+ company profiles of medical equipment manufacturers in Japan • 1,200+ companies’ revenue splits and market shares • 1,600+ quarterly and annual medical equipment company financials • 850+ medical equipment company SWOTs • 28,000+ pipeline product profiles • 56,400+ marketed product profiles • 47,000+ clinical trials • 41,500+ trial investigators • 7,000+ reports on companies with products in development • 44,000+ deals in the medical equipment industry • 1,100+ surgical and diagnostic procedures by therapy area • 50+ key healthcare indicators by country • 431,000+ Themes Content Items • 600+ Influencers • 1,900+ Analysts & Researchers • 0.5m+ Community Members • 141,000+ Macroeconomic Indicators • 1,013,000+ City Indicators For more information or to receive a free demonstration of the service, please visit: https://medical.globaldata.com/home.aspx Custom Requirements Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Mineralocorticoid Receptor (Nuclear Receptor Subfamily 3 Group C Member 2 or Mineralocorticoid Receptor Delta or Aldosterone Receptor or MR or NR3C2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Mineralocorticoid Receptor (Nuclear Receptor Subfamily 3 Group C Member 2 or Mineralocorticoid Receptor Delta or Aldosterone Receptor or MR or NR3C2) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report analyses the pipeline products across relevant therapy areas under development and provides an overview of key players involved in Mineralocorticoid Receptor (Nuclear Receptor Subfamily 3 Group C Member 2 or Mineralocorticoid Receptor Delta or Aldosterone Receptor or MR or NR3C2) targeted therapeutics development and features dormant and discontinued projects.

Menopausal Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Menopausal Disorders pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Menopausal Disorders, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lymphoblastic Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lymphoblastic Lymphoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: * This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase. * Certain sections in the report may be removed or altered based on the availability and relevance of data. * Global Markets Direct, is a research brand owned and operated by GlobalData.

Lafora Disease (Unverricht Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lafora Disease (Unverricht Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Lafora Disease (Unverricht Disease), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The over-the-counter (OTC) healthcare market in Italy was valued at $3.8 billion in 2021. The market is projected to grow at a CAGR of less than 1% during the forecast period. The Italy OTC healthcare market was led by cough and cold preparations in value terms. However, the medicated skin products category is forecasted to register the fastest value growth during 2021-2026. Within the distribution channels, drug stores & pharmacies were the largest distribution channel in the Italy OTC healthcare sector.

The Italy OTC healthcare market report provides insights on high-growth markets to target, trends in the usage of category level distribution data, and companies market shares.

The key regions in the interstitial cystitis clinical trials market are Asia-Pacific, Middle East & Africa, Europe, North America, and Central & South America.

Interstitial cystitis clinical trial market in Asia -Pacific

Japan, South Korea, Taiwan, India, Australia are the key countries in the Asia- Pacific region in the interstitial cystitis clinical trials market. Among them Japan has the highest number of clinical trials.

Interstitial cystitis clinical trial market in Europe

The UK, Italy, Germany, Russia, and Netherlands are the key countries in Europe in the interstitial cystitis clinical trials market. Among them the UK has the highest number of clinical trials.

Interstitial cystitis clinical trial market in North America

The US and Canada are the top countries in the North American region in the interstitial cystitis clinical trials market. Among them the US has the highest number of clinical trials, followed by Canada.

The Influenza A Virus, H5N1 Subtype Infections pipeline market report provides a comprehensive overview on the therapeutics under development for Influenza A Virus, H5N1 Subtype Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects.

External ventricular drainage is a kit along with a small tube surgically inserted that allows the temporary drainage of CSF from the ventricles of the brain, which helps to relieve intracranial pressure. Microtransducer devices are used primarily for the measurement of ICP.

The ICP monitoring devices pipeline market research report provides comprehensive information about the ICP monitoring devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides key insights on major pipeline products, including product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.

Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Human Parainfluenza Virus 3 Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Human Parainfluenza Virus 3 Infections, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: * This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase. * Certain sections in the report may be removed or altered based on the availability and relevance of data. * Global Markets Direct, is a research brand owned and operated by GlobalData.

Hepatitis C Virus Envelope Protein E1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Hepatitis C Virus Envelope Protein E1 targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Additionally, the report analyses the pipeline products across relevant therapy areas under development and provides an overview of key players involved in Hepatitis C Virus Envelope Protein E1 targeted therapeutics development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The Angola beverages market size was 553.3 million liters (ML) in Q1 2022. The Angola beverages market report, covering soft drinks, dairy drinks, hot drinks, and alcoholic drinks is an essential tool for keeping up to date with the latest industry performance and developments on a quarterly basis. The key segments in the Angola beverages market are soft drinks, hot drinks, dairy and soy drinks and milk alternatives, and alcoholic drinks. Soft drinks had the highest volume in the Angola beverages market in Q2 2022.

Soft Drinks

Soft drinks can be further segmented into packaged water, flavored water, carbonates, juice, nectars, still drinks, squash/syrups, fruit powders, iced/RTD tea drinks, iced/RTD coffee drinks, sports drinks, energy drinks, and bulk/HOD water. In Q2 2022, within the segment, carbonates had the highest volume in the Angola beverages market.

Hot Drinks

Hot drinks can be further segmented into hot coffee, hot tea, and other hot drinks. In Q22022, within the segment, hot coffee had the highest volume in the Angola beverages market.

The key categories in the Algeria beverages market are soft drinks, hot drinks, alcoholic drinks, and dairy & soy drinks & milk alternatives. Soft drinks had the highest market share in the Algeria beverages market in Q1 2022.

Soft Drinks: The soft drinks category can be further segmented into packaged water, carbonates, juice, nectars, still drinks, squash/syrups, fruit powders, iced/RTD tea drinks, iced/RTD coffee drinks, sports drinks, and energy drinks. Packaged water was the largest segment in the Algeria soft drinks category in Q1-2022.

Hot Drinks: The hot drinks category can be further segmented into hot coffee, hot tea, and other hot drinks. Hot coffee was the largest segment in the Algeria hot drinks category in Q1-2022.

Alcoholic Drinks: The alcoholic drinks category can be further segmented into beer, flavored alcoholic beverages, fortified wine, brandy, gin & genever, liqueurs, rum, sparkling wine, still wine, tequila & mezcal, vodka, and whiskey. Beer was the largest segment in the Algeria alcoholic drinks category in Q1-2022.

The Ghana insurance market size was $764.6 million in 2021. The market is expected to grow at a CAGR of more than 17% from 2020 to 2025.

The Ghana insurance market research report provides a detailed outlook by product category for the Ghanaian insurance industry. It provides values for key performance indicators such as gross written premium, penetration, premium accepted and ceded, profitability ratios, and premium by line of business, during the review period and forecast period. The report also analyzes distribution channels operating in the segment and gives a comprehensive overview of the Ghanaian economy and demographics. Moreover, it provides detailed information on the competitive landscape in the country and includes details of insurance regulations and recent changes in the regulatory structure.